U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07448883) titled 'Validity of the Turkish Translation of the Modified JOA' on Feb. 27.
Brief Summary: Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic spinal cord dysfunction in adults and may lead to progressive motor, sensory, and autonomic impairment. Accurate and standardized assessment of neurological function is essential for clinical decision-making, prognostic evaluation, and comparison of treatment outcomes. The Modified Japanese Orthopaedic Association (mJOA) score is one of the most widely used clinician-based outcome measures for evaluating neurological status in patients with DCM. Although the mJOA has bee...